268 related articles for article (PubMed ID: 17210383)
1. The effect of supervised exercise and cilostazol on coagulation and fibrinolysis in intermittent claudication: a randomized controlled trial.
Hobbs SD; Marshall T; Fegan C; Adam DJ; Bradbury AW
J Vasc Surg; 2007 Jan; 45(1):65-70; discussion 70. PubMed ID: 17210383
[TBL] [Abstract][Full Text] [Related]
2. The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplasty.
Hobbs SD; Marshall T; Fegan C; Adam DJ; Bradbury AW
J Vasc Surg; 2006 Jan; 43(1):40-6. PubMed ID: 16414385
[TBL] [Abstract][Full Text] [Related]
3. Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial.
Kakkos SK; Geroulakos G; Nicolaides AN
Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):164-75. PubMed ID: 15890545
[TBL] [Abstract][Full Text] [Related]
4. Supervised exercise training for intermittent claudication: lasting benefit at three years.
Ratliff DA; Puttick M; Libertiny G; Hicks RC; Earby LE; Richards T
Eur J Vasc Endovasc Surg; 2007 Sep; 34(3):322-6. PubMed ID: 17587612
[TBL] [Abstract][Full Text] [Related]
5. A non-randomised controlled trial of the clinical and cost effectiveness of a Supervised Exercise Programme for claudication.
Lee HL; Mehta T; Ray B; Heng MS; McCollum PT; Chetter IC
Eur J Vasc Endovasc Surg; 2007 Feb; 33(2):202-7. PubMed ID: 17142065
[TBL] [Abstract][Full Text] [Related]
6. Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up.
Delis KT; Nicolaides AN; Wolfe JH; Stansby G
J Vasc Surg; 2000 Apr; 31(4):650-61. PubMed ID: 10753272
[TBL] [Abstract][Full Text] [Related]
7. Rapid foot and calf compression increases walking distance in patients with intermittent claudication: results of a randomized study.
Ramaswami G; D'Ayala M; Hollier LH; Deutsch R; McElhinney AJ
J Vasc Surg; 2005 May; 41(5):794-801. PubMed ID: 15886663
[TBL] [Abstract][Full Text] [Related]
8. Changes in thrombin generation, fibrinolysis, platelet and endothelial cell activity, and inflammation following endovascular abdominal aortic aneurysm repair.
Abdelhamid MF; Davies RS; Adam DJ; Vohra RK; Bradbury AW
J Vasc Surg; 2012 Jan; 55(1):41-6. PubMed ID: 21975058
[TBL] [Abstract][Full Text] [Related]
9. Gender differences following supervised exercise therapy in patients with intermittent claudication.
Gommans LN; Scheltinga MR; van Sambeek MR; Maas AH; Bendermacher BL; Teijink JA
J Vasc Surg; 2015 Sep; 62(3):681-8. PubMed ID: 26304482
[TBL] [Abstract][Full Text] [Related]
10. The effects of cilostazol on exercise-induced ischaemia-reperfusion injury in patients with peripheral arterial disease.
O'Donnell ME; Badger SA; Sharif MA; Makar RR; McEneny J; Young IS; Lee B; Soong CV
Eur J Vasc Endovasc Surg; 2009 Mar; 37(3):326-35. PubMed ID: 19112032
[TBL] [Abstract][Full Text] [Related]
11. All patients benefit equally from a supervised exercise program for claudication.
Serracino-Inglott F; Owen G; Carter A; Dix F; Smyth JV; Mohan IV
Vasc Endovascular Surg; 2007; 41(3):212-6. PubMed ID: 17595387
[TBL] [Abstract][Full Text] [Related]
12. The effect of a 3-month supervised exercise programme on gait parameters of patients with peripheral arterial disease and intermittent claudication.
King S; Vanicek N; Mockford KA; Coughlin PA
Clin Biomech (Bristol, Avon); 2012 Oct; 27(8):845-51. PubMed ID: 22663776
[TBL] [Abstract][Full Text] [Related]
13. Exercise training enhances endogenous fibrinolysis in peripheral arterial disease.
Killewich LA; Macko RF; Montgomery PS; Wiley LA; Gardner AW
J Vasc Surg; 2004 Oct; 40(4):741-5. PubMed ID: 15472603
[TBL] [Abstract][Full Text] [Related]
14. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial.
Dawson DL; Cutler BS; Meissner MH; Strandness DE
Circulation; 1998 Aug; 98(7):678-86. PubMed ID: 9715861
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of cilostazol, a novel phosphodiesterase inhibitor in patients with intermittent claudication.
Samra SS; Bajaj P; Vijayaraghavan KS; Potdar NP; Vyas D; Devani RG; Ballary C; Desai A
J Indian Med Assoc; 2003 Sep; 101(9):561-2, 564. PubMed ID: 15168999
[TBL] [Abstract][Full Text] [Related]
16. A prospective randomized controlled study with intermittent mechanical compression of the calf in patients with claudication.
de Haro J; Acin F; Florez A; Bleda S; Fernandez JL
J Vasc Surg; 2010 Apr; 51(4):857-62. PubMed ID: 20347681
[TBL] [Abstract][Full Text] [Related]
17. Supervised exercise therapy for intermittent claudication in a community-based setting is as effective as clinic-based.
Bendermacher BL; Willigendael EM; Nicolaï SP; Kruidenier LM; Welten RJ; Hendriks E; Prins MH; Teijink JA; de Bie RA
J Vasc Surg; 2007 Jun; 45(6):1192-6. PubMed ID: 17543684
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication.
Lee TM; Su SF; Tsai CH; Lee YT; Wang SS
Clin Sci (Lond); 2001 Sep; 101(3):305-11. PubMed ID: 11524048
[TBL] [Abstract][Full Text] [Related]
19. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication.
Mazari FA; Gulati S; Rahman MN; Lee HL; Mehta TA; McCollum PT; Chetter IC
Ann Vasc Surg; 2010 Jan; 24(1):69-79. PubMed ID: 19762206
[TBL] [Abstract][Full Text] [Related]
20. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease.
Money SR; Herd JA; Isaacsohn JL; Davidson M; Cutler B; Heckman J; Forbes WP
J Vasc Surg; 1998 Feb; 27(2):267-74; discussion 274-5. PubMed ID: 9510281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
